Imed Infinity Medical-Limited Partnership reported earnings results for the half year ended June 30, 2022. For the half year, the company reported net loss was USD 0.801 million compared to USD 0.493 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 0.1 a year ago.

Diluted loss per share from continuing operations was USD 0.2.